Search

Search Constraints

You searched for: Author/Creator Hayes, C Nelson

Search Results

1. Combination Therapies with Daclatasvir and Asunaprevir on NS3-D168 Mutated HCV in Human Hepatocyte Chimeric Mice. Issue 4 (May 2016)

2. Combination therapies with NS5A, NS3 and NS5B inhibitors on different genotypes of hepatitis C virus in human hepatocyte chimeric mice. Issue 7 (15th January 2013)

3. Correction: Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: A pilot study. Issue 8 (November 2018)

5. Effect of prolonged administration of pegylated interferon/ribavirin therapy in genotypes 2a and 2b: Propensity score‐matched analysis. Issue 2 (February 2015)

6. Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg‐interferon, and ribavirin combination treatment for chronic hepatitis C. Issue 12 (5th April 2016)

7. HCV substitutions and IL28B polymorphisms on outcome of peg-interferon plus ribavirin combination therapy. Issue 2 (10th November 2010)

9. Real‐world efficacy and safety of daclatasvir and asunaprevir therapy for hepatitis C virus‐infected cirrhosis patients. Issue 3 (March 2017)

10. Reduction of hepatitis B surface antigen in sequential versus add-on pegylated interferon to nucleoside/nucleotide analogue therapy in HBe-antigen-negative chronic hepatitis B patients: A pilot study. Issue 8 (November 2018)